Therapeutic Asset Ratings

3,186 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
a2b694 Ovarian Neoplasm	A2 Biotherapeutics Inc.	P1/2	D (19)
a2b694 Malignant Pancreatic Neoplasm	A2 Biotherapeutics Inc.	P1/2	D (19)
Autologous Bcma/Cd38 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	D (19)
Autologous Cd33/Cd123 Dual-Target Car-T Module Plasma Cell Myeloma	Beijing Biotech	P1/2	D (19)
Autologous Cd33/Cll1 Dual-Target Car-T Module Plasma Cell Myeloma	Beijing Biotech	P1/2	D (19)
Bcma-Cart Cells Plasma Cell Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1/2	D (19)
cd70.car nk cells Large B-Cell Lymphoma	M.D. Anderson Cancer Center	P2	D (18)
21.15.gpc3-car t cells Wilms Tumor	Baylor College of Medicine	P1	D (18)
Autologous Anti-Cd83 Car T-Cells Acute Myeloid Leukemia	Roswell Park Cancer Institute	P1	D (18)
Autologous Mesothelin-Specific Tcr-T Cells Pancreatic Ductal Adenocarcinoma	Fred Hutchinson Cancer Center	P1	D (18)
b7-h3-car t cells Medulloblastoma	St. Jude Children's Research Hospital	P1	D (18)
cd22 car-t Mantle Cell Lymphoma	Stanford University	P1	D (18)
cd22 car-transduced t cells Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	Ohio State University Comprehensive Cancer Center	P1	D (18)
cd22 car-transduced t cells B-Cell Prolymphocytic Leukemia	Sumithira Vasu	P1	D (18)
cd22 car-transduced t cells Chronic Myeloid Leukemia	Ohio State University Comprehensive Cancer Center	P1	D (18)
her3 - primed dendritic cells Triple-Negative Breast Carcinoma	H. Lee Moffitt Cancer Center and Research Institute	P1	D (18)
Sc-Car.Gpc3Xil15.21 Car T Cells Wilms Tumor	Seattle Children's Hospital	P1	D (18)
Wu-Cart-007 Extranodal Nasal NK/T Cell Lymphoma	Washington University School of Medicine	P1	D (18)
Anti Cd30 Car-T Cell Angioimmunoblastic T-Cell Lymphoma	Zhejiang University	Early P1	D (18)
cd70-targeting car-t cells Plasma Cell Myeloma	Zhejiang University	Early P1	D (18)
Autologous Cd33/Cd123 Dual-Target Car-T Module T-Cell Acute Lymphoblastic Leukemia	Beijing Biotech	P1/2	D (18)
Autologous Cd33/Cd123 Dual-Target Car-T Module B-Cell Acute Lymphoblastic Leukemia	Beijing Biotech	P1/2	D (18)
Autologous Cd33/Cd123 Dual-Target Car-T Module T-Lymphoblastic Lymphoma	Beijing Biotech	P1/2	D (18)
Autologous Cd5/Cd7 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	D (18)

Showing 2926 to 2950 of 3,186 assets

PreviousPage 118 of 128Next